News Releases

Medexus Announces New License Deal for Topical Terbinafine

Medexus Announces New License Deal for Topical Terbinafine   TORONTO and CHICAGO, March 22, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that the company has secured Canadian rights to commercialize terbinafine...